People familiar with the talks revealed Nov. 5 that the retail pharmacy chain was exploring options to take the company private as it struggles to adapt to the changing pharmacy landscape. On Nov. 11, private equity firm KKR & Co. made a formal offer to buy Walgreens.
Walgreens senior management has been quiet since reports of the deal surfaced three months ago, according to Forbes.
This may mean the shareholder meeting on Jan. 30 may be the first public discussion about the deal and whether shareholders would support it.
The meeting is being held in Wilmington, Del.
More articles on pharmacy:
Drug shortages update: 5 things to know
Grocery store pharmacies across the country finding it harder to stay in business
AbbVie to donate $1M of drug China says will combat coronavirus
